Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
JSPR holding history
Jasper Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JSPR overviewAll 13F holders of JSPRFull Q4 2025 holdings
- Shares (Q4 2025)
- 1,326,512
- Value
- $2.43M
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 1,326,512 | $2.43M | <0.1% | +293,670+28.4% | Added | Holders |
| Q3 2025 | 1,032,842 | $2.46M | <0.1% | +408,245+65.4% | Added | Holders |
| Q2 2025 | 624,597 | $3.47M | <0.1% | −54,855−8.1% | Reduced | Holders |
| Q1 2025 | 679,452 | $2.92M | <0.1% | −30,032−4.2% | Reduced | Holders |
| Q4 2024 | 709,484 | $15.2M | <0.1% | +15,059+2.2% | Added | Holders |
| Q3 2024 | 694,425 | $13.1M | <0.1% | +4,366+0.6% | Added | Holders |
| Q2 2024 | 690,059 | $15.7M | <0.1% | +77,314+12.6% | Added | Holders |
| Q1 2024 | 612,745 | $18.0M | <0.1% | −3,480,213−85.0% | Reduced | Holders |
| Q4 2023 | 4,092,958 | $3.23M | <0.1% | +300,000+7.9% | Added | Holders |
| Q3 2023 | 3,792,958 | $2.66M | <0.1% | +104,600+2.8% | Added | Holders |
| Q2 2023 | 3,688,358 | $5.05M | <0.1% | −37,789−1.0% | Reduced | Holders |
| Q1 2023 | 3,726,147 | $6.74M | <0.1% | +3,195,709+602.5% | Added | Holders |
| Q4 2022 | 530,438 | $256.1K | <0.1% | +318+0.1% | Added | Holders |
| Q3 2022 | 530,120 | $418.0K | <0.1% | +49,559+10.3% | Added | Holders |
| Q2 2022 | 480,561 | $928.0K | <0.1% | +2,737+0.6% | Added | Holders |
| Q1 2022 | 477,824 | $1.70M | <0.1% | −5,679−1.2% | Reduced | Holders |
| Q4 2021 | 483,503 | $3.79M | <0.1% | +483,503 | New | Holders |